Vascular Grafts Market by Product (Hemodialysis Access Grafts, Endovascular Stents Graft, and Peripheral Vascular Graft), Raw Material (Polyester Vascular Grafts, Polytetrafluoroethylene Vascular Grafts, Polyurethane Vascular Grafts, and Biological Material Based Vascular Grafts), Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, and Coronary Artery Disease): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026877 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 3.49 billion mark in 2022 and is expected to hit US$ 6.41 billion by 2030, recording a CAGR of 7.92% during the forecast period.

Vascular grafts market has been significantly growing due to increasing kidney diseases. Globally, there is a rising chronic kidney diseases and increasing dialysis procedures which drives the growth of vascular grafts market. According to Centers for Disease Control and Prevention, in 2021, about 3 million people in the US suffer from chronic kidney diseases. Further, growing cases of cardiovascular disease, diabetes, and end-stage renal disease are driving the growth of vascular grafts market. According to World Health Organization, cardiovascular disease is the leading cause of death in the US and about 17.9 million died due to cardiovascular disease in 2019. Vascular grafts are performed to bypass artery by redirecting blood from an area of normal blood flow to another relatively normal area. The endovascular stent grafts segment is expected to dominate due to rising adoption of endovascular stent grafts to treat aneurysms that includes thoracic aortic aneurysms. Thus, aforementioned factors are expected boost the growth of vascular graft market  during the forecasted year.

Within the report, the market is segmented into product, raw material, application, and geography. By product, the market is further segmented into hemodialysis access grafts, endovascular stents grafts, and peripheral vascular graft. Based on raw material, the market is segmented into polyester vascular grafts, polytetrafluoroethylene vascular grafts, polyurethane vascular grafts, and biological material based vascular grafts. By application, the market is categorized into cardiac aneurysm, kidney failure, vascular occlusion, and coronary artery disease. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Rising prevalence of cardiac diseases drives the growth of vascular grafts market in the North America region.

The vascular grafts market in the North America region is expected to grow due to rising cardiac diseases and initiatives taken by key players to manage the disease. Further, increasing investments by governments and rapidly growing geriatric population boost the growth of vascular grafts market.

Advancement in tissue-engineered grafts is expected to promote the growth of vascular grafts market.

The rising cases of hypertension, cholesterol levels due to sedentary lifestyle and growing geriatric population increases the risk of cardiac aneurysm. The technological development in advanced tissue-engineered grafts to perform heart surgeries is propelling the growth of vascular grafts market. Further, the increasing incidences of organ transplant failure and surgical reconstruction for cardiovascular disease seeks minimally invasive vascular implants. Thus, aforementioned factors are expected to boost the growth of vascular grafts market.

Recent strategic developments in vascular grafts market

The vascular grafts market has undergone several significant developments, and a few of these have been mentioned below:

  • In November 2019, Terumo Corporation acquired Aortic Corporation which helped the growth of vascular grafts market by contributing to personalized aortic therapy.
  • In May 2022, the US Davis received USD 3 million from CIRM (California Institute for Regenerative Medicine) to develop smart vascular graft for kidney patients.
  • In July 2021, Vascudyne, Inc introduced first in-human vascular graft, TRUE, for its end-stage renal disease patients who requires hemodialysis access.

The vascular grafts market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Medtronic plc; Getinge AB; LeMaitre Vascular Inc; WL Gore and Assocaites, Inc; Cook Medical; CR Bard; Terumo Corporation; and Shanghai Suokang Medical Implants Co. Ltd. are among the prominent players operating in the market.

Target audience for the report:

  • Hospitals
  • Specialty Clinics
  • Cardiac Care Centers
  • Vascular Grafts Manufacturers

Scope of the report:

In this report, the market has been segmented based on:

  • Product
    • Hemodialysis Access Grafts
    • Endovascular Stents Grafts
    • Peripheral Vascular Graft
  • Raw Material
    • Polyester Vascular Grafts
    • Polytetrafluoroethylene Vascular Grafts
    • Polyurethane Vascular Grafts
    • Biological Material Based Vascular Grafts
  • Application
    • Cardia Aneurysm
    • Kidney Failure
    • Vascular Occlusion
    • Coronary Heart Disease
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Medtronic plc
    • Getinge AB
    • LeMaitre Vascular Inc
    • WL Gore and Assocaites, Inc
    • Cook Medical
    • CR Bard
    • Terumo Corporation
    • Shanghai Suokang Medical Implants Co. Ltd.

The List of Companies
- Medtronic plc
- Getinge AB
- LeMaitre Vascular Inc
- WL Gore and Assocaites, Inc
- Cook Medical
- CR Bard
- Terumo Corporation
- Shanghai Suokang Medical Implants Co. Ltd.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000